Long Term Outcomes of a Steroid Free, Low Dose Tacrolimus with Everolimus Regimen in Kidney Transplant.

被引：0
作者：
Kassis, Y. [1 ]
Park, S. [1 ]
Shetty, A. [1 ]
Leventhal, J. [1 ]
Mas, V. [2 ]
Gallon, L. [1 ]
机构：
[1] Northwestern Univ, Comprehens Transplant Ctr, Chicago, IL 60611 USA
[2] Univ Virginia, Dept Surg, Charlottesville, VA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C94
引用
收藏
页码：800 / 801
页数：2
相关论文
共 50 条
  • [41] Steroid-Free Quadruple Induction Regimen With Basiliximab, Everolimus, Mycophenolate and Very Low Dose Tacrolimus Reduces Incidence of Biopsy-Proven Acute Rejection and Toxicity Profile Compared to the Standard Triple Regimen
    Miura, M.
    Higashiyama, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [42] Long-Term Outcomes of Thymoglobulin Induced Kidney Transplant Recipients Maintained on Tacrolimus vs Belatacept
    Kagan, Mackenzie
    Yang, Christine
    Tang, Rocky
    Tsapepas, Demetra
    Mohan, Sumit
    Cohen, David
    Ratner, Lloyd
    Hardy, Mark
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (01) : S76 - S76
  • [43] Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients
    Kaplan, Adam
    Young, Jo-Anne H.
    Kandaswamy, Raja
    Berglund, Danielle
    Knoll, Bettina M.
    Sieger, Gretchen
    Cavert, Winston
    Matas, Arthur
    Obeid, Karam M.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2020, 2020
  • [44] The short- and long-term outcomes of steroid-free regimen in liver transplantation.
    Sasaki, Kazuki
    Kobayashi, Shogo
    Marubashi, Shigeru
    Iwagami, Yoshifumi
    Yamada, Daisaku
    Tomimaru, Yoshito
    Noda, Takehiro
    Takahashi, Hidenori
    Doki, Yuichiro
    Eguchi, Hidetoshi
    TRANSPLANTATION, 2024, 108 (9S)
  • [45] Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: Results of a randomized trial
    Toenshoff, Burkhard
    Ettenger, Robert
    Dello Strologo, Luca
    Marks, Stephen D.
    Pape, Lars
    Tedesco-Silva Jr, Helio
    Bjerre, Anna
    Christian, Martin
    Meier, Matthias
    Martzloff, El-Djouher
    Rauer, Barbara
    Ng, Jennifer
    Lopez, Patricia
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (03) : 811 - 822
  • [46] The short- and long-term outcomes of steroid-free regimen in liver transplantation.
    Sasaki, Kazuki
    Kobayashi, Shogo
    Marubashi, Shigeru
    Iwagami, Yoshifumi
    Yamada, Daisaku
    Tomimaru, Yoshito
    Noda, Takehiro
    Takahashi, Hidenori
    Doki, Yuichiro
    Eguchi, Hidetoshi
    TRANSPLANTATION, 2024, 108 (09) : 243 - 243
  • [47] Conversion from sirolimus to everolimus in kidney transplant recipients receiving a calcineurin-free regimen
    Carvalho, Catarina
    Coentrao, Luis
    Bustorff, Manuela
    Patricio, Emilia
    Sampaio, Susana
    Santos, Joana
    Oliveira, Gerardo
    Pestana, Manuel
    CLINICAL TRANSPLANTATION, 2011, 25 (04) : E401 - E405
  • [48] Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus
    Shihab, F.
    Qazi, Y.
    Mulgaonkar, S.
    McCague, K.
    Patel, D.
    Peddi, V. R.
    Shaffer, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (09) : 2363 - 2371
  • [49] Low doses of everolimus plus tacrolimus for ABO-incompatible kidney-transplant recipients
    Rostaing, Lionel
    Esposito, Laure
    Allal, Asma
    Sallusto, Federico
    Debiol, Benedicte
    Kamar, Nassim
    XENOTRANSPLANTATION, 2013, 20 (05) : 321 - 321
  • [50] SERUM MARKERS OF HEPATITIS-B VIRUS (HBV) AND KIDNEY-TRANSPLANT IN A LOW-DOSE STEROID REGIMEN
    SQUICCIMARRO, G
    TRIOLO, G
    MESSINA, M
    ROSSETTI, M
    MALFI, B
    STRATTA, P
    SEGOLONI, GP
    VERCELLONE, A
    KIDNEY INTERNATIONAL, 1985, 28 (02) : 387 - 387
12345